Home » Topics » BioWorld Science

BioWorld Science
RSS

KLB as a novel druggable target for the prevention of NAFLD

July 1, 2022

Roche discovers new EGFR mutant inhibitors for NSCLC

July 1, 2022

Stingray Therapeutics synthesizes ENPP1 inhibitors

July 1, 2022

Tuojie Biotech identifies new P2X3 antagonists

July 1, 2022

Qurient Therapeutics discloses new CDK7 inhibitors

July 1, 2022

Albireo patents SLC10A1 and/or SLC10A2 inhibitors

July 1, 2022

Thrombospondin-1 found to be involved in pathogenesis of acute-on-chronic liver failure

July 1, 2022

CRV-431 is a possible treatment approach for ALD

July 1, 2022

Anti-VISTA monoclonal antibody KVA-12.1 produces antitumor responses in vivo

June 30, 2022

IAMA reports responses with selective NKCC1 inhibitors in animal models of Down syndrome and autism

June 30, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...